AFM

Anson Funds Management Portfolio holdings

AUM $548M
1-Year Return 253.35%
This Quarter Return
+8.12%
1 Year Return
+253.35%
3 Year Return
+225.27%
5 Year Return
+203.49%
10 Year Return
+1,566.82%
AUM
$374M
AUM Growth
+$231M
Cap. Flow
+$209M
Cap. Flow %
55.79%
Top 10 Hldgs %
36.52%
Holding
205
New
109
Increased
7
Reduced
25
Closed
36

Top Buys

1
LCID icon
Lucid Motors
LCID
$23.1M
2
GOAC.U
GO Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-third of on
GOAC.U
$16.8M
3
CRHC.U
Cohn Robbins Holdings Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CRHC.U
$10.9M
4
AVAN
Avanti Acquisition Corp.
AVAN
$10.3M
5
SEAH.U
Sports Entertainment Acquisition Corp. Units, each consisting of one share of Class A Common Stock,
SEAH.U
$10M

Top Sells

1
DM
Desktop Metal, Inc.
DM
$8.9M
2
FREE
Whole Earth Brands, Inc. Class A Common Stock
FREE
$7.42M
3
AMRN
Amarin Corp
AMRN
$6.18M
4
MOV icon
Movado Group
MOV
$5.51M
5
BFT.U
Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an
BFT.U
$4.95M

Sector Composition

1 Financials 10.27%
2 Healthcare 9.01%
3 Consumer Discretionary 8.8%
4 Real Estate 6.73%
5 Materials 2.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MTLS
126
Materialise
MTLS
$294M
$271K 0.05%
+5,000
New +$271K
AKBA icon
127
Akebia Therapeutics
AKBA
$801M
$267K 0.05%
+95,342
New +$267K
CTAC.U
128
DELISTED
Cerberus Telecom Acquisition Corp. Units, each consisting of one Class A ordinary share and one-thir
CTAC.U
$267K 0.05%
+25,000
New +$267K
FLACU
129
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$260K 0.05%
+25,000
New +$260K
BMY icon
130
Bristol-Myers Squibb
BMY
$95B
$249K 0.05%
+360,700
New +$249K
CLPS icon
131
CLPS Inc
CLPS
$29.1M
$249K 0.05%
+81,814
New +$249K
KIN
132
DELISTED
Kindred Biosciences, Inc.
KIN
$247K 0.05%
+57,277
New +$247K
MTVA
133
MetaVia Inc. Common Stock
MTVA
$16.6M
$239K 0.05%
+190
New +$239K
PHIOW
134
DELISTED
Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
$232K 0.05%
+86,299
New +$232K
INBS icon
135
Intelligent Bio Solutions
INBS
$13.6M
$230K 0.05%
+129
New +$230K
ETTX
136
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$229K 0.05%
+92,626
New +$229K
NNOX icon
137
Nano X Imaging
NNOX
$238M
$228K 0.05%
+5,000
New +$228K
RAPT icon
138
RAPT Therapeutics
RAPT
$211M
$217K 0.04%
+1,371
New +$217K
SIEB icon
139
Siebert Financial
SIEB
$103M
$210K 0.04%
+49,896
New +$210K
ATXS icon
140
Astria Therapeutics
ATXS
$395M
$209K 0.04%
+16,267
New +$209K
LIXT icon
141
Lixte Biotechnology
LIXT
$20.4M
$181K 0.04%
+5,711
New +$181K
CODA icon
142
Coda Octopus Group
CODA
$90M
$176K 0.04%
+28,016
New +$176K
NERV icon
143
Minerva Neurosciences
NERV
$16.2M
$163K 0.03%
+8,692
New +$163K
TC
144
TuanChe
TC
$420M
$154K 0.03%
+154
New +$154K
IBRX icon
145
ImmunityBio
IBRX
$2.26B
$133K 0.03%
+10,000
New +$133K
ACIC.U
146
DELISTED
Atlas Crest Investment Corp. Units, each consisting of one Class A common stock, and one-third of on
ACIC.U
$106K 0.02%
+10,000
New +$106K
QD
147
Qudian
QD
$741M
$98K 0.02%
+70,940
New +$98K
SONM icon
148
Sonim Technologies
SONM
$10.5M
$97K 0.02%
+1,335
New +$97K
SMHI icon
149
SEACOR Marine Holdings
SMHI
$175M
$88K 0.02%
+32,480
New +$88K
CATX icon
150
Perspective Therapeutics
CATX
$263M
$87K 0.02%
+19,318
New +$87K
4 5
6
7 8